|
FCHSD2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.629000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.570600E-01 |
| Normal-vs-Stage2 |
1.737400E-01 |
| Normal-vs-Stage3 |
7.287600E-01 |
| Normal-vs-Stage4 |
6.328600E-01 |
| Stage1-vs-Stage2 |
3.360500E-02 |
| Stage1-vs-Stage3 |
3.562600E-01 |
| Stage1-vs-Stage4 |
3.496200E-01 |
| Stage2-vs-Stage3 |
2.469400E-01 |
| Stage2-vs-Stage4 |
3.639800E-01 |
| Stage3-vs-Stage4 |
8.630400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.249800E-01 |
| Normal-vs-AfricanAmerican |
5.592500E-02 |
| Normal-vs-Asian |
7.334200E-01 |
| Caucasian-vs-AfricanAmerican |
1.689700E-02 |
| Caucasian-vs-Asian |
5.246200E-01 |
| AfricanAmerican-vs-Asian |
8.559800E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.537000E-01 |
| Normal-vs-Female |
9.191400E-01 |
| Male-vs-Female |
7.189600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.555600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.533000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.360400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.358800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.156100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.245900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.333200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.112200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.672600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.950800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.068200E-01 |
| Classical-VS-Follicular |
6.958500E-04 |
| Classical-VS-Other |
2.929000E-01 |
| Classical-VS-Normal |
5.093600E-01 |
| Tall-VS-Follicular |
6.304200E-02 |
| Tall-VS-Other |
3.043600E-01 |
| Tall-VS-Normal |
7.253800E-01 |
| Follicular-VS-Other |
9.242200E-01 |
| Follicular-VS-Normal |
8.593700E-02 |
| Other-VS-Normal |
4.675200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.997800E-01 |
| Normal-vs-N1 |
7.145400E-01 |
| N0-vs-N1 |
5.678000E-01 |
|
|
